These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 7615809

  • 1. The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor.
    Burger D, Chicheportiche R, Giri JG, Dayer JM.
    J Clin Invest; 1995 Jul; 96(1):38-41. PubMed ID: 7615809
    [Abstract] [Full Text] [Related]

  • 2. In vitro modulation of cytokine, cytokine inhibitor, and prostaglandin E release from blood mononuclear cells and synovial fibroblasts by antirheumatic drugs.
    Seitz M, Loetscher P, Dewald B, Towbin H, Baggiolini M.
    J Rheumatol; 1997 Aug; 24(8):1471-6. PubMed ID: 9263137
    [Abstract] [Full Text] [Related]

  • 3. Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors.
    Torcia M, Lucibello M, Vannier E, Fabiani S, Miliani A, Guidi G, Spada O, Dower SK, Sims JE, Shaw AR, Dinarello CA, Garaci E, Cozzolino F.
    Exp Hematol; 1996 Jul; 24(8):868-74. PubMed ID: 8690044
    [Abstract] [Full Text] [Related]

  • 4. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D, Bianchi A, Boyault S, Sebillaud S, Koufany M, Francois M, Netter P, Jouzeau JY, Terlain B.
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [Abstract] [Full Text] [Related]

  • 5. An interleukin 1 receptor antagonist blocks the IL-1-induced IL-6 paracrine production through a prostaglandin E2-related mechanism in multiple myeloma.
    Lu ZY, Bataille R, Poubelle P, Rapp MJ, Harousseau JL, Klein B.
    Stem Cells; 1995 Aug; 13 Suppl 2():28-34. PubMed ID: 8520508
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of granuloma formation induced by potassium permanganate in the mouse by a specific human recombinant receptor antagonist for interleukin-1 (hrIL-1ra).
    Conti P, Panara MR, Fridas S, Barbacane RC, Grilli A, Placido FC, Reale M, Fiore S.
    Cell Immunol; 1993 Apr 01; 147(2):446-57. PubMed ID: 8384086
    [Abstract] [Full Text] [Related]

  • 7. Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production.
    Seckinger P, Klein-Nulend J, Alander C, Thompson RC, Dayer JM, Raisz LG.
    J Immunol; 1990 Dec 15; 145(12):4181-4. PubMed ID: 2147937
    [Abstract] [Full Text] [Related]

  • 8. Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell.
    Andersson J, Björk L, Dinarello CA, Towbin H, Andersson U.
    Eur J Immunol; 1992 Oct 15; 22(10):2617-23. PubMed ID: 1396967
    [Abstract] [Full Text] [Related]

  • 9. A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer.
    Gouze JN, Gouze E, Palmer GD, Liew VS, Pascher A, Betz OB, Thornhill TS, Evans CH, Grodzinsky AJ, Ghivizzani SC.
    Arthritis Res Ther; 2003 Oct 15; 5(5):R301-9. PubMed ID: 12932294
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis.
    Hart PH, Ahern MJ, Smith MD, Finlay-Jones JJ.
    Immunology; 1995 Apr 15; 84(4):536-42. PubMed ID: 7790026
    [Abstract] [Full Text] [Related]

  • 11. Aceclofenac increases the synthesis of interleukin 1 receptor antagonist and decreases the production of nitric oxide in human articular chondrocytes.
    Maneiro E, López-Armada MJ, Fernández-Sueiro JL, Lema B, Galdo F, Blanco FJ.
    J Rheumatol; 2001 Dec 15; 28(12):2692-9. PubMed ID: 11764219
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-1 receptor antagonist intervenes in signaling between different types of synoviocytes in rats with adjuvant arthritis.
    Zheng YQ, Wei W, Dai M, Zhu L, Jia XY, Wang Y.
    Acta Pharmacol Sin; 2006 Jan 15; 27(1):111-8. PubMed ID: 16364217
    [Abstract] [Full Text] [Related]

  • 13. Intracellular IL-1 receptor antagonist is elevated in human dermal fibroblasts that overexpress intracellular precursor IL-1 alpha.
    Higgins GC, Wu Y, Postlethwaite AE.
    J Immunol; 1999 Oct 01; 163(7):3969-75. PubMed ID: 10490999
    [Abstract] [Full Text] [Related]

  • 14. The interleukin-1 receptor antagonist and its delivery by gene transfer.
    Evans CH, Robbins PD.
    Receptor; 1994 Oct 01; 4(1):9-15. PubMed ID: 8038709
    [Abstract] [Full Text] [Related]

  • 15. Differential binding of human interleukin-1 (IL-1) receptor antagonist to natural and recombinant soluble and cellular IL-1 type I receptors.
    Svenson M, Nedergaard S, Heegaard PM, Whisenand TD, Arend WP, Bendtzen K.
    Eur J Immunol; 1995 Oct 01; 25(10):2842-50. PubMed ID: 7589081
    [Abstract] [Full Text] [Related]

  • 16. Direct contact with stimulated T cells induces the expression of IL-1beta and IL-1 receptor antagonist in human monocytes. Involvement of serine/threonine phosphatases in differential regulation.
    Vey E, Dayer JM, Burger D.
    Cytokine; 1997 Jul 01; 9(7):480-7. PubMed ID: 9237810
    [Abstract] [Full Text] [Related]

  • 17. Activation of the peroxisome proliferator-activated receptor alpha pathway potentiates interleukin-1 receptor antagonist production in cytokine-treated chondrocytes.
    François M, Richette P, Tsagris L, Fitting C, Lemay C, Benallaoua M, Tahiri K, Corvol MT.
    Arthritis Rheum; 2006 Apr 01; 54(4):1233-45. PubMed ID: 16572457
    [Abstract] [Full Text] [Related]

  • 18. Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines.
    Burger D, Rezzonico R, Li JM, Modoux C, Pierce RA, Welgus HG, Dayer JM.
    Arthritis Rheum; 1998 Oct 01; 41(10):1748-59. PubMed ID: 9778216
    [Abstract] [Full Text] [Related]

  • 19. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.
    Arend WP, Malyak M, Smith MF, Whisenand TD, Slack JL, Sims JE, Giri JG, Dower SK.
    J Immunol; 1994 Nov 15; 153(10):4766-74. PubMed ID: 7963543
    [Abstract] [Full Text] [Related]

  • 20. Induction of prostaglandin H synthase-2 and tumor necrosis factor-alpha in human amnionic WISH cells by various stimuli occurs through distinct intracellular mechanisms.
    Hulkower KI, Otis ER, Li J, Ennis BW, Cugier DJ, Bell RL, Carter GW, Glaser KB.
    J Pharmacol Exp Ther; 1997 Feb 15; 280(2):1065-74. PubMed ID: 9023325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.